Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein.
Wang Y, Ding X, Wang S, Moser CD, Shaleh HM, Mohamed EA, Chaiteerakij R, Allotey LK, Chen G, Miyabe K, McNulty MS, Ndzengue A, Barr Fritcher EG, Knudson RA, Greipp PT, Clark KJ, Torbenson MS, Kipp BR, Zhou J, Barrett MT, Gustafson MP, Alberts SR, Borad MJ, Roberts LR. Wang Y, et al. Among authors: gustafson mp. Cancer Lett. 2016 Sep 28;380(1):163-73. doi: 10.1016/j.canlet.2016.05.017. Epub 2016 May 20. Cancer Lett. 2016. PMID: 27216979 Free PMC article.
Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.
Mertens JC, Fingas CD, Christensen JD, Smoot RL, Bronk SF, Werneburg NW, Gustafson MP, Dietz AB, Roberts LR, Sirica AE, Gores GJ. Mertens JC, et al. Among authors: gustafson mp. Cancer Res. 2013 Jan 15;73(2):897-907. doi: 10.1158/0008-5472.CAN-12-2130. Epub 2012 Dec 5. Cancer Res. 2013. PMID: 23221385 Free PMC article.
Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors.
Bornschlegl S, Gustafson MP, Delivanis DA, Ryder M, Liu MC, Vasmatzis G, Hallemeier CL, Park SS, Roberts LR, Parney IF, Jelinek DF, Dietz AB. Bornschlegl S, et al. Among authors: gustafson mp. Clin Transl Immunology. 2021 Apr 29;10(4):e1267. doi: 10.1002/cti2.1267. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33968403 Free PMC article.
Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patients.
Hingorani P, Maas ML, Gustafson MP, Dickman P, Adams RH, Watanabe M, Eshun F, Williams J, Seidel MJ, Dietz AB. Hingorani P, et al. Among authors: gustafson mp. J Immunother Cancer. 2015 Aug 18;3:35. doi: 10.1186/s40425-015-0082-0. eCollection 2015. J Immunother Cancer. 2015. PMID: 26286851 Free PMC article.
Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine.
Knutson KL, Block MS, Norton N, Erskine CL, Hobday TJ, Dietz AB, Padley D, Gustafson MP, Puglisi-Knutson D, Mangskau TK, Chumsri S, Dueck AC, Karyampudi L, Wilson G, Degnim AC. Knutson KL, et al. Among authors: gustafson mp. Clin Cancer Res. 2020 Mar 1;26(5):1045-1053. doi: 10.1158/1078-0432.CCR-19-2123. Epub 2019 Nov 22. Clin Cancer Res. 2020. PMID: 31757875 Free PMC article. Clinical Trial.
63 results